Ordenar

Buscar

09/05/2023 Oral Health Interventions in Natural Disasters: A Scoping Review
Suzuki-Barrera, K, Teramoto, A, Saez-Chandia, J, Nakakuki, K, Bracchiglione, J. Oral Health Interventions in Natural Disasters: A Scoping Review. Disaster Medicine and Public Health Preparedness. 2023; 17(12)DOI:10.1017/dmp.2023.62. PMID:37157874. IF:1.900(Q3/6D).
09/05/2023 Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia (vol 10, 50, 2021)
Zhu, NL, Santos-Santos, M, Illan-Gala, I, Montal, V, Estelles, T, Barroeta, I, Altuna, M, Arranz, J, Munoz, L, Belbin, O, Sala, I, Sanchez-Saudinos, MB, Subirana, A, Videla, L, Pegueroles, J, Blesa, R, Clarimon, J, Carmona-Iragui, M, Fortea, J, Lleo, A, Alcolea, D. Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia (vol 10, 50, 2021). Translational Neurodegeneration. 2023; 12(1)DOI:10.1186/s40035-023-00351-3. PMID:37158972. IF:10.800(Q1/1D).
09/05/2023 Transcriptional diversity in specific synaptic gene sets discriminates cortical neuronal identity
Adam, AR, Martínez-López J.A., van der Spek, SJF, Sullivan, PF, Smit, AB, Hjerling-Leffler, J, Achsele, T, Andres-Alonso, M, Bagni, C, Bayes, A, Biederer, T, Brose, N, Chua, JJE, Coba, MP, Cornelisse, LN, de Juan-Sanz, J, Goldschmidt, HL, Gundelfinger, ED, Huganir, RL, Imig, C, Jahn, R, Jung, HJ, Kaeser, PS, Kim, E, Koopmans, F, Kreutz, MR, Lipstein, N, MacGillavry, HD, McPherson, PS, O'Connor, V, Pielot, R, Ryan, TA, Sala, C, Sheng, MR, Smalla, KH, Thomas, PD, Toonen, RF, van Weering, JRT, Verhage M., Verpelli, C. Transcriptional diversity in specific synaptic gene sets discriminates cortical neuronal identity. Biology Direct. 2023; 18(1)DOI:10.1186/s13062-023-00372-y. PMID:37161421. IF:5.700(Q1/1D).
08/05/2023 Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study
Goh, SY, Kosiborod, MN, Lam, CSP, Cavender, MA, Kohsaka, S, Norhammar, A, Birkeland, KI, Holl, RW, Mauricio, D, Tangri, N, Shaw, JE, Thuresson, M, Fenici, P, Kim, DJ. Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study. DIABETES OBESITY & METABOLISM. 2023; 25(8)DOI:10.1111/dom.15092. PMID:37055714. IF:5.400(Q1/2D).